Reproductive Medicine Center
Basic description: With the postponement of the age of parenthoods, the increasing pressure of social life, and the increase in the demand for second births of geriatric pregnancy after releasing the second child policy by China government, about 1 in 7 couples (according to World Health Organization) has difficulties in fertility. This has led to higher technical requirements and higher demands in fertility testing of the Reproductive Medicine Center.
WESAIL Reproductive Medicine Center Solution
Provide routine parameter for fertility detection:
1. Assessment of ovarian reserve function and its level is not affected by menstrual cycle, hormonal contraceptives and pregnancy.
2. Assisted reproduction
The AMH level can accurately predict the patient's response to controlled ovarian stimulation (COS), and personalize a treatment plan accordingly.
3. Other clinical applications
AMH has been confirmed to be a specific circulating indicator of granular cell tumors, and its diagnostic sensitivity is between 76% and 93%. The serum AMH level is directly proportional to the size of ovarian granular cell tumors, and is directly related to the results of imaging. AMH can also indicate the recurrence of granular cell tumors 11 months earlier than other clinical indicators.
1. InhB and ovarian reserve assessment
Women with decreased ovarian reserve are firstly observed with decrease in basal InhB level.
2. InhB and prediction of ovarian responsiveness
Basal InhB level and InhB level on the fifth day of FSH injection can be used to predict ovarian responsiveness.
3. InhB and polycystic ovary syndrome (PCOS)
The serum InhB level of PCOS patients was significantly higher than normal population.
4. InhB and premature ovarian failure (POF)
The serum InhB level of POF patients was significantly lower than normal population.
5. InhB and peri-menopause
Serum InhB level decreases with the decline of ovarian reserve. Serum InhB indicates peri-menopause earlier than FSH and E2.